Ge Zhongming, Feng Yan, Muthupalani Sureshkumar, Whary Mark T, Versalovic James, Fox James G
Division of Comparative Medicine, Massachusetts Institute of Technology, Cambridge, MA , USA.
Helicobacter. 2014 Aug;19(4):280-8. doi: 10.1111/hel.12135. Epub 2014 May 23.
Helicobacter pylori cholesterol-α-glucosyltransferase (cgt) is essential for survival of H. pylori in mice. Enterohepatic H. hepaticus, the cause of colonic and hepatocellular carcinoma in susceptible mouse strains, contains an ortholog of the H. pylori cgt. However, the role of cgt in the pathogenesis of H. hepaticus has not been investigated.
Two cgt-deficient isogenic mutants of wild-type H. hepaticus (WT) 3B1 were generated and used to inoculate male A/JCr mice. Cecal and hepatic colonization levels of the mutants and WT 3B1 as well as select inflammation-associated cytokines were measured by qPCR at 4 months postinoculation.
Both mutants were undetectable in the cecum of any inoculated mice (10 per mutant) but were detected in two livers (one for each mutant); by contrast, 9 and 7 of 10 mice inoculated with WT 3B1 were qPCR positive in the ceca and livers, respectively. The mice inoculated with the mutants developed significantly less severe hepatic inflammation (p < .05) and also produced significantly lower hepatic mRNA levels of proinflammatory cytokines Ifn-γ (p < .01) and Tnf-α (p ≤ .02) as well as anti-inflammatory factors Il10 and Foxp3 compared with the WT 3B1-inoculated mice. Additionally, the WT 3B1-inoculated mice developed significantly higher Th1-associated IgG2a (p < .0001) and Th2-associated IgG1 responses (p < .0001) to H. hepaticus infection than mice dosed with isogenic cgt mutants.
Our data indicate that the cholesterol-α-glucosyltransferase is required for establishing colonization of the intestine and liver and therefore plays a critical role in the pathogenesis of H. hepaticus.
幽门螺杆菌胆固醇-α-葡萄糖基转移酶(cgt)对幽门螺杆菌在小鼠体内的存活至关重要。肝肠螺杆菌是易感小鼠品系中结肠癌和肝细胞癌的病因,它含有幽门螺杆菌cgt的直系同源物。然而,cgt在肝肠螺杆菌发病机制中的作用尚未得到研究。
构建了野生型肝肠螺杆菌(WT)3B1的两个cgt缺陷同基因突变体,并用于接种雄性A/JCr小鼠。在接种后4个月,通过qPCR测量突变体和WT 3B1的盲肠和肝脏定植水平以及选定的炎症相关细胞因子。
在任何接种小鼠(每个突变体10只)的盲肠中均未检测到这两个突变体,但在两个肝脏中检测到(每个突变体一个);相比之下,接种WT 3B1的10只小鼠中,分别有9只和7只在盲肠和肝脏中qPCR呈阳性。与接种WT 3B1的小鼠相比,接种突变体的小鼠发生的肝脏炎症明显较轻(p < 0.05),促炎细胞因子Ifn-γ(p < 0.01)和Tnf-α(p ≤ 0.02)以及抗炎因子Il10和Foxp3的肝脏mRNA水平也显著降低。此外,与接种同基因cgt突变体的小鼠相比,接种WT 3B1的小鼠对肝肠螺杆菌感染产生的Th1相关IgG2a(p < 0.0001)和Th2相关IgG1反应显著更高(p < 0.0001)。
我们的数据表明,胆固醇-α-葡萄糖基转移酶是肠道和肝脏定植所必需的,因此在肝肠螺杆菌的发病机制中起关键作用。